参考文献/References:
［1］ Zhang J, Jin H, Liu H, et al. MiRNA 99a directly regulates AGO2 through translational repression in hepatocellular carcinoma［J］. Oncogenesis, 2014, 3: e97.
［2］ Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association［J］. Hepatology, 2012, 55: 2005 2023.
［3］ Pan K, Li YQ, Wang W, et al. The efficacy of Cytokine Induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients［J］. Ann Surg Oncol, 2013, 20: 4305 4311.
［4］ Lencioni R, Petruzzi P, Crocetti L, et al. Chemoembolization of hepatocellular carcinoma［J］． Semin Intervent Radiol, 2013, 30: 3 11.
［5］ 谭智勇， 黄 婕， 龚建平， 等． CIK细胞在肝癌治疗中的研究进展［J］． 中国医药指南， 2014， 12： 99 102．
［6］ 邓武坚， 陈锦武， 罗颖嘉， 等． 微创治疗联合自体CIK细胞输注对肝癌的疗效及安全性研究［J］． 岭南现代临床外科， 2013， 13： 29 31．
［7］ Lauvau G, Chorro L, Spaulding E, et al. Inflammatory monocyte effector mechanisms［J］. Cell Immunol, 2014, 291: 32 40.
［8］ Shirabe K, Motomura T, Muto J, et al. Tumor infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management［J］. Int J Clin Oncol, 2010, 15: 552 558.
［9］ Jiang J, Wu C, Lu B, et al. Cytokine induced killer cells promote antitumor immunity［J］. J Transl Med, 2013, 11: 83.
［10］ 盛立霞， 邱国强， 谢晓宝， 等． 两种白血病细胞抗原负载DC的体外诱导特异性CTL应答的比较［J］． 细胞与分子免疫学杂志， 2005， 21： 205 209．
［11］ Molla N, Almenieir N, Simoneau E, et al. The role of interventional radiology in the management of hepatocellular carcinoma［J］. Curr Oncol, 2014, 21: e480 e492.
［12］李懿珺， 徐 立， 陈敏山， 等． 栓塞化疗对肝癌患者细胞亚群的影响及其与临床疗效的关系［J］． 消化肿瘤杂志（电子版）， 2011， 3： 35 39．
［13］ 彭启全， 李升平， 徐 立， 等． 117例肝癌患者外周血调节T细胞水平及其临床意义［J］． 癌症， 2007， 26： 748 751．
相似文献/References:
[1]姚雪松,李 槐.不可手术切除的肝细胞癌的疗效评价标准——改良ＲＥＣＩＳＴ标准更可靠[J].介入放射学杂志,2012,(03):177.
. Ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ ｃｒｉｔｅｒｉｏｎ ｏｆ ｉｎｏｐｅｒａｂｌｅ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ｍｏｄｉｆｉｅｄ ＲＥＣＩＳＴ ａｓ ａ ｍｏｒｅ ｒｅｌｉａｂｌｅ ｓｔａｎｄａｒｄ[J].journal interventional radiology,2012,(05):177.
[2]程洁敏,王建华.喜树碱微球化疗栓塞治疗原发性肝癌10例报告[J].介入放射学杂志,1993,(01):47.
[3]梁茂全,苏洪英. 肝癌化疗栓塞前后甲胎蛋白变化模式的临床意义[J].介入放射学杂志,2012,(04):333.
.Ｔｈｅ ｔｒａｎｓｆｏｒｍａｔｉｏｎ ｐａｔｔｅｒｎ ｏｆ ｓｅｒｕｍ аｆｅｔｏｐｒｏｔｅｉｎ ａｆｔｅｒ ｔｒａｎｓｃａｔｈｅｔｅｒ ａｒｔｅｒｉａｌ ｃｈｅｍｏｅｍｂｏｌｉｚａｔｉｏｎ ｉｎ ｐａｔｉｅｎｔｓ ｗｉｔｈ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａ： ｉｔｓ ｃｌｉｎｉｃａｌ ｓｉｇｎｉｆｉｃａｎｃｅ [J].journal interventional radiology,2012,(05):333.
[4]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
.Ｔｈｅ ｖｏｌｕｍｅ ｏｆ Ｌｉｐｉｏｄｏｌ ｕｓｅｄ ｉｎ ＴＡＣＥ： ｉｔｓ ｃｕｒｒｅｎｔ ｓｉｔｕａｔｉｏｎ ａｎｄ ｒｅｓｅａｒｃｈ ｐｒｏｇｒｅｓｓ [J].journal interventional radiology,2012,(05):348.
[5]卢丽琴,陈方宏,袁建华,等.晚期肝癌伴门脉癌栓的介入治疗[J].介入放射学杂志,1996,(03):136.
[6]孙 磊,施海彬,刘 圣,等.肝细胞癌肝动脉门静脉分流形成的相关因素分析[J].介入放射学杂志,2012,(03):206.
,,et al.Ｔｈｅ ｆａｃｔｏｒｓ ｒｅｌａｔｅｄ ｔｏ ｔｈｅ ｆｏｒｍａｔｉｏｎ ｏｆ ａｒｔｅｒｉｏｐｏｒｔａｌ ｓｈｕｎｔｉｎｇ ｉｎ ｐａｔｉｅｎｔｓ ｗｉｔｈ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ [J].journal interventional radiology,2012,(05):206.
[7]姚红响,陈根生,诸葛英,等.肝动脉化疗栓塞联合ＣＴ引导射频消融序贯治疗中小肝癌的临床应用[J].介入放射学杂志,2012,(04):301.
,,et al.Ｓｅｑｕｅｎｔｉａｌ ｔｒｅａｔｍｅｎｔ ｗｉｔｈ ＴＡＣＥ ａｎｄ ＣＴｇｕｉｄｅｄ ＲＦＡ ｆｏｒ ｓｍａｌｌ ａｎｄ ｍｏｄｅｒａｔｅ ｓｉｚｅｄ ＨＣＣ [J].journal interventional radiology,2012,(05):301.
[8]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗３０例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｍａｓｓｉｖｅ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａ ｃｌｉｎｉｃａｌ ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ [J].journal interventional radiology,2012,(05):322.
[9]沈海洋,刘瑞宝,刘 岩,等. 肝右叶前、后段原发性肝癌TACE后VEGF及CD34的表达水平 ；[J].介入放射学杂志,2012,(06):469.
SHEN Hai- yang,LIU Rui- bao,LIU Yan,et al. The expression levels of vascular endothelial growth factor and CD34 in residual cancerous tissues of primary hepatocellular carcinoma located at anterior and posterior segments of right lobe liver after TACE[J].journal interventional radiology,2012,(05):469.
[10]李晓峰,钱国军,张 磊,等. 微波高功率条件下消融原发性肝癌的初步研究[J].介入放射学杂志,2011,(12):974.
LI Xiao-feng,QIAN Guo-jun,ZHANG Lei,et al.Microwave ablation with high output power for the treatment of hepatocellular carcinoma: a preliminary study[J].journal interventional radiology,2011,(05):974.
[11]黄文薮,蔡明岳,曾昭吝,等.TACE联合125I放射性粒子植入治疗肝细胞癌门静脉癌栓[J].介入放射学杂志,2015,(06):488.
HUANG Wen- sou,CAI Ming- yue,ZENG Zhao- lin,et al.Transarterial chemoembolization combined with CT- guided 125I seed implantation for the treatment of hepatocellular carcinoma associated with portal vein tumor thrombus[J].journal interventional radiology,2015,(05):488.
[12]刘德鑫,王 伟,李新丰,等.肝动脉化疗栓塞联合粒子植入治疗肝癌自发性破裂出血的临床研究[J].介入放射学杂志,2015,(11):999.
LIU De- xin,WANG Wei,LI Xin- feng,et al.TACE combined with radioactive seed implantation for the treatment of abdominal hemorrhage due to spontaneous rupture of primary hepatocellular carcinoma： a clinical study[J].journal interventional radiology,2015,(05):999.
[13]刘 毅,卓 琳,朱 蓓,等.肝动脉化疗栓塞联合经皮消融治疗肝细胞癌疗效的meta分析 [J].介入放射学杂志,2017,(09):830.
LIU Yi,ZHUO Lin,ZHU Bei,et al.Transcatheter arterial chemoembolization in combination with percutaneous ablation therapy for the treatment of hepatocellular carcinoma： a meta- analysis[J].journal interventional radiology,2017,(05):830.
[14]陆 阳,姜永能,万 程,等.阿帕替尼联合TACE治疗中晚期肝细胞癌的疗效研究[J].介入放射学杂志,2019,28(02):162.
LU Yang,JIANG Yongneng,WAN Cheng,et al.Curative effect of apatinib combined with TACE for advanced hepatocellular carcinoma[J].journal interventional radiology,2019,28(05):162.
[15]苏 珂,徐尧阳,郭 露,等.肝动脉化疗栓塞联合卡瑞利珠单抗治疗中晚期肝细胞癌的疗效分析[J].介入放射学杂志,2022,31(09):865.
SU Ke,XU Yaoyang,GUO Lu,et al.Hepatic arterial chemoembolization combined with camrelizumab for the treatment of mid-to-advanced hepatocellular carcinoma： analysis of its curative efficacy[J].journal interventional radiology,2022,31(05):865.
[16]刘晓侃,洪 鑫,许若男,等.CT影像组学联合血清炎症参数预测肝癌根治术后辅助TACE的早期复发[J].介入放射学杂志,2023,32(11):1075.
LIU Xiaokan,HONG Xin,XU Ruonan,et al.CT radiomics combined with serum inflammatory parameters in predicting early recurrence of hepatocellular carcinoma after radical resection followed by adjuvant TACE[J].journal interventional radiology,2023,32(05):1075.